Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Diabetes
100%
Blood Pressure
100%
Vascular Disease
100%
Gliclazide
100%
Indapamide Plus Perindopril
100%
Microangiopathy
75%
Macrovascular Disease
75%
Glucose
75%
Maturity Onset Diabetes of the Young
50%
Perindopril
50%
Indapamide
50%
Randomized Controlled Trial
25%
Apoplexy
25%
Placebo
25%
Myocardial Infarction
25%
Patient with Type 2 Diabetes
25%
Sulfonylurea
25%
Nephropathy
25%
ACE Inhibitor
25%
Diabetes Mellitus
25%
Treatment Duration
25%
Glycemic Control
25%
Diuretics
25%
Eye Disease
25%
Cardiovascular System
25%
Pharmacology, Toxicology and Pharmaceutical Science
Gliclazide
100%
Vascular Disease
100%
Indapamide Plus Perindopril
100%
Maturity Onset Diabetes of the Young
100%
Microangiopathy
100%
Glucose
100%
Indapamide
66%
Perindopril
66%
Placebo
33%
Randomized Controlled Trial
33%
Cerebrovascular Accident
33%
Diseases
33%
Heart Infarction
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Kidney Disease
33%
Diabetes Mellitus
33%
Diuretics
33%
Sulfonylurea
33%
Eye Disease
33%
Keyphrases
Pressure Concentration
33%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
33%